Skin Analytics Valuation Estimate
Skin Analytics Valuation as of Last Funding Round
Skin Analytics Company Overview
Skin Analytics operates a skin cancer screening platform that provides artificial intelligence-supported teledermatology services to support clinicians in assessing skin lesions. Skin Analytics is working with the NHS to build world-leading skin cancer pathways using the only UKCA Class IIa AI as a medical device for dermatology to deliver better patient outcomes sustainably. Skin Analytics was also part of the DigitalHealth.London Accelerator program. Skin Analytics has raised $5.27 million over eight rounds, with notable investments from the National Health Service, Hoxton Ventures, and Mustard Seed Ventures.
Skin Analytics Valuation History
Skin Analytics Stock Price
The stock price of Skin Analytics can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming Skin Analytics has issued 250 million shares, at the estimated UpMarket valuation of $23.88 million, each share of Skin Analytics stock would be worth $0.10.
Buy Skin Analytics Stock
If you would like to buy shares in Skin Analytics, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss Skin Analytics stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Skin Analytics as well.
Skin Analytics Management
Name | Position |
---|---|
Neil Daly | CEO |
Jim Holmes | CTO |
David Puttergill | COO |